Aqueous composition for the sterilization of infectious microorganisms, and method for sterilization using the same
An aqueous composition with persulfate compounds effectively sterilizes bacterial spores at low temperatures and normal pressure, addressing the limitations of existing methods by achieving high sterility assurance levels and safety in sterilizing various materials.
Patent Information
- Application Number
- JP2023086953
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-26
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2043-05-26
AI Technical Summary
Existing sterilization methods are inadequate for efficiently sterilizing bacterial spores with high resistance under normal pressure and below 100°C, without using ethylene oxide gas or glutaraldehyde, and there is a need for a safer and more versatile oxidizing agent.
An aqueous composition containing a persulfate compound, optionally with an alkaline compound, is used to sterilize infectious microorganisms at temperatures below 100°C, effectively decomposing bacterial spores through oxidation.
The composition achieves high sterilization efficiency, reducing bacterial spores to a sterility assurance level of 10^-6 or less, without generating harmful gases and at lower temperatures, suitable for a wide range of materials including medical devices and disposable diapers.
Smart Images

Figure 2024170034000001 
Figure 2024170034000002
Abstract
Description
[Technical field]
[0001] The present invention relates to an aqueous composition for sterilizing infectious microorganisms and a sterilization method using the same. [Background technology]
[0002] The "Guidelines for Disinfection and Sterilization" (supervised by the Tuberculosis and Infectious Diseases Division, Health and Medical Bureau, Ministry of Health and Welfare; edited by Kobayashi Hiroi, Health Publishing, 2000) provides detailed information on methods for disinfection and inactivation of infectious diseases covered by the New Infectious Diseases Law, as well as methods for disinfecting and sterilizing contaminated materials (instruments, patient environments, linens, etc.). Although the book refers to disinfection and sterilization methods, the contents of the book suggest that it is more appropriate to understand this as inactivation within the scope of sterilization, which does not necessarily mean the complete annihilation of bacteria, but rather inactivation to the extent that bacteria are no longer harmful. The book also has an independent chapter on "sterilization methods." According to this chapter, "the concept of sterilization is probabilistic, and sterilization is complete only when a state in which a preset sterility assurance level (SAL) has been reached and maintained" and "a sterility assurance level of 10% or more is required for sterility assurance level to be reached." -6 "A level of sterilization has been adopted," which means that the probability of a single microorganism surviving sterilization is one in a million. These principles are still followed today, and sterility assurance levels are set at 10. -6 has been adopted ("Guidelines for Disinfection and Sterilization" Revised 4th Edition (2020) by Okubo Ken et al., Health Publishing).
[0003] According to the "Guidelines for Sterility Assurance in Medical Settings 2015" (Japan Society of Medical Devices), the relevant international standard guidelines state that the indicator bacteria Geobacillus stearothermophilus (bacterial spores described below) should be 1x10 5 The required performance is indicated as CFU or more (bacterial count of less than one in 100,000). In addition, for infectious waste (waste that contains or is attached to pathogens that cause or are likely to cause infection in humans, or waste that is likely to cause such infection) designated as specially controlled waste in the "Manual for Infectious Waste Disposal Based on the Waste Disposal Act" (March 2018, Environmental Regeneration and Resource Recycling Bureau, Ministry of the Environment), the Waste Disposal and Public Cleansing Act and the Enforcement Order of said Act provide specific explanations on the specific procedures required to ensure the proper disposal of such waste. The manual's document (Reference 9) "Methods for confirming effectiveness in the treatment of infectious waste" lists (1) Bacillus stearothermophilus (ATCC 7953) and (2) Bacillus subtilis var. niger (ATCC 9372) as the biological indicators with the highest resistance to sterilization. In addition to these Bacillus spores, spores of Clostridium spores (tetanus and gas anthrax group) and anthrax (Bacillus anthracis) have the same sterilization resistance as (1) and (2) above, but for safety reasons, they are inactivated (sterility assurance level 10) using (1) and (2). -6 It is advisable to check the following:
[0004] The aforementioned "Guidelines for Disinfection and Sterilization" and "Infectious Waste Disposal Manual Based on the Waste Disposal Law" state that sterility assurance level 10 -6 It is described that the following sterilization methods are widely used to sterilize sterilization-resistant bacterial spores: 1) heating methods (high-pressure steam method at 115-129°C, dry heat method at 160-190°C), 2) gas methods (ethylene oxide gas sterilization, hydrogen peroxide gas plasma sterilization), 3) irradiation methods (gamma ray irradiation, electron beam irradiation), and other methods. However, the heating method requires an autoclave and is economical, but is limited by the treatment conditions of high temperature and high pressure.The gas method using ethylene oxide can sterilize at low temperature, so there is no change in the material due to heating, but the sterilization time is long and a method is used to reduce the residual gas after treatment and the health hazard to workers.
[0005] In fact, the "Practical Guide to Hospital Infection Control for Clinical Laboratory Technologists" (Japan Association of Medical Technologists, 2005) states that clinical laboratories pose a risk of carrying in many pathogens, and that physiological tests and blood sampling involve direct contact with patients. Although not mentioned in the guide, one example is the Osaka District Court ruling (December 25, 2006) regarding exposure to glutaraldehyde. Furthermore, "Prevention of health damage to workers caused by glutaraldehyde in medical institutions" (Ministry of Health, Labour and Welfare, 2005) was notified to the president and members of the Japan Hospital Association. Reference 1 of the notice lists eight cases of work-related accidents caused by glutaraldehyde that occurred in domestic medical institutions between 1999 and 2004. Furthermore, Reference 3 of the notice lists various health hazards caused by phthalal preparations and peracetic acid, which are alternative sterilizing disinfectants to glutaraldehyde for use in sterilizing medical instruments such as endoscopes.
[0006] Under these circumstances, various methods are being implemented for disinfecting and sterilizing a wide variety of medical devices and instruments, as well as the patient environment and secretions and excretions. However, none of the methods are necessarily satisfactory, and there is a need for the development of a sterilization method that operates at normal pressure, below 100°C, and that does not use ethylene oxide gas, glutaraldehyde, etc.
[0007] Patent Document 1 describes a 1% mixture of 50% potassium persulfate and 5% sulfamic acid in distilled water as various disinfectant mixtures for nanobacteria related to apatite mineral formation. However, Patent Document 1 describes that an effective method for eradicating the nanobacteria is to dissolve apatite (mineral) with ethylenediaminetetraacetic acid in the first step, and a commercial product consisting of a peroxy acid compound, a surfactant, an organic acid, and an inorganic buffer system in the second step. Therefore, Patent Document 1 does not specifically describe a sterilization method using a mixture of potassium persulfate and sulfamic acid. And the technology described in Patent Document 1 could not kill Bacillus stearothermophilus.
[0008] In addition, potassium persulfate contains potassium hydrogen peroxomonosulfate (K + 0-S0 2 -0-0H, also known as potassium hydrogen persulfate) Potassium peroxodisulfate (K 2 S 2 0 8 There are two types: potassium persulfate (abbreviated as KPS). The former is a strong oxidizing agent, but is unstable in aqueous solution, so it is used as the main component in environmental disinfectants and cleaning agents. The latter decomposes into two molecules in aqueous solution or organic solvent at about 60°C to become active radicals and is used as a polymerization initiator. Both are often called potassium persulfate, but their chemical properties are significantly different.
[0009] Non-Patent Document 1 reports that the effectiveness of an environmental disinfectant and cleaner (RST) whose main ingredient is potassium hydrogen peroxomonosulfate (potassium hydrogen persulfate) was tested on methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Pseudomonas aeruginosa (MDRP), and that 1% RST increased the infection rate by 4 log with an action time of 1 minute. 10 or higher (sterility assurance level 10 -4 It has been reported that potassium hydrogen peroxomonosulfate oxidizes the sodium chloride contained in it, and the hypochlorous acid (HClO) produced during the reaction exhibits a strong antimicrobial effect. Patent Document 2 reports water purification at room temperature by sterilizing bacteria such as cyanobacteria and fungi using an aqueous solution of a precursor that generates chlorine dioxide and active oxygen compounds consisting of sulfur-containing oxyacids (a mixture of oxidizing agents including potassium hydrogen persulfate, KPS, etc.), alkali metal carbonates, and chlorites. However, all of the methods described in these documents are unable to kill bacterial spores at a sterility assurance level of 10. -6 This is not a sterilization method that can be achieved.
[0010] As described above, disinfection or sterilization methods using peroxides such as potassium persulfate have been reported. However, none of these methods have been effective in sterilizing (1) Bacillus stearothermophilus (ATCC 7953) and (2) Bacillus subtilis var. niger (ATCC 9372), which are the most sterilization-resistant biological indicators, in an oxidizing agent solution containing peroxide.
[0011] Patent Document 3 states that at least 4 log 10 A technology is described in which a treatment method exhibiting a bactericidal effect of about 100% is used to sterilize bacterial spores at room temperature over a long period of time using an aqueous solution of peracetic acid in the first stage and an aqueous solution of hydrogen peroxide in the second stage. However, although the names of peroxomonosulfuric acid and peroxodisulfuric acid are described as peroxidizing agents in this document, potassium hydrogen peroxomonosulfate and potassium peroxodisulfate are not specified, and no persulfate compounds are described in the examples. Furthermore, although the names of bacterial spores such as Bacillus stearothermophilus and Bacillus subtilis are described, only a two-stage sterilization method at room temperature is introduced, and there is no description at all that the aqueous solutions of peroxomonosulfuric acid and peroxodisulfuric acid are appropriate. Thus, the technology described in Patent Document 3 kills bacterial spores in a KPS aqueous solution at a rate of 6 log 10 or higher (sterility assurance level 10 -6 ) sterilization.
[0012] As described above, the present inventors have conducted an intensive search of patent documents both in Japan and abroad, but have not found any reports of complete sterilization of bacterial spores using radicals obtained by thermal decomposition of KPS in an aqueous solution at a temperature of 60°C or higher. [Prior art documents] [Patent documents]
[0013] [Patent Document 1] Special Publication No. 2002-519363 [Patent Document 2] Special Publication No. 2008-507399 [Patent Document 3] US Patent Application Publication No. 2015 / 0305343 A1 [Non-patent literature]
[0014] [Non-Patent Document 1] Environmental Infection, Vol. 30, 391-398 (2015) Summary of the Invention [Problem to be solved by the invention]
[0015] The present invention has been made in consideration of the above circumstances, and an object of the present invention is to provide a new aqueous composition for sterilization of infectious microorganisms that can efficiently sterilize bacterial spores having the highest sterilization resistance using a cheaper and more versatile oxidizing agent, and a sterilization method using the same. [Means for solving the problem]
[0016] In order to solve the above problems, the present inventors have conducted extensive research into decomposition agents that can efficiently sterilize infectious microorganisms. As a result, they have discovered that an aqueous solution containing a persulfate compound as a decomposition agent not only has superior sterilization performance compared to conventional chemical agents, but can also be used efficiently in a safe environment under mild conditions of 100°C or less, and that no decomposition products of infectious microorganisms or the decomposition agent remain on solid surfaces after sterilization and cleaning treatments. Based on these findings, the present invention has been completed.
[0017] That is, the present invention is as follows. [1] An aqueous composition for sterilization for sterilizing infectious microorganisms, comprising a persulfate compound. [2] The aqueous composition for sterilization described in [1], wherein the persulfate compound is water-soluble. [3] The aqueous composition for sterilization according to [1] or [2], wherein the persulfate compound is peroxodisulfate. [4] The aqueous composition for sterilization according to any one of [1] to [3], wherein the concentration of the persulfate compound in the aqueous composition for sterilization is 0.01% by weight or more and not exceeding the saturation concentration. [5] The aqueous composition for sterilization according to any one of [1] to [4], further comprising an alkaline compound. [6] The aqueous composition for sterilization according to any one of [1] to [5], wherein the pH of the aqueous composition for sterilization is in the range of 1 to 10. [7] A method for sterilizing an infectious microorganism, comprising a step of sterilizing an object to be treated containing the infectious microorganism using the aqueous composition for sterilization according to any one of [1] to [6]. [8] The sterilization method according to [7], wherein the infectious microorganisms are dispersed in water, dispersed in a water-absorbent polymer gel, or attached or adsorbed to a solid surface. [9] The sterilization method according to [7], wherein the object to be sterilized is a medical tool or medical device.
[10] The sterilization method according to [9], wherein the medical equipment is medical protective clothing.
[11] The sterilization method according to [7], wherein the object to be sterilized is a paper diaper.
[12] The sterilization method according to [7], wherein the object to be sterilized is food. Effect of the Invention
[0018] According to the aqueous composition for sterilization of infectious microorganisms of the present invention and the sterilization method using the same, bacterial spores having the highest sterilization resistance can be efficiently sterilized using a cheaper and more versatile oxidizing agent. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0019] Hereinafter, embodiments of the aqueous composition for sterilization of infectious microorganisms and the sterilization method using the same of the present invention will be described in detail.
[0020] The infectious microorganisms that are subjected to sterilization using the aqueous sterilization composition of the present invention are bacterial spores, which have the highest sterilization resistance, but all of the infectious microorganisms of Classes 1 to 5 that are subject to the Infectious Diseases Control Act are also exemplified as targets.
[0021] The aqueous composition for sterilization of the present invention contains a persulfate compound as an oxidizing agent. More preferably, the aqueous composition for sterilization of the present invention further contains an alkaline compound. The persulfate compound is not particularly limited, and potassium persulfate (potassium peroxodisulfate, KPS), sodium persulfate (sodium peroxodisulfate), ammonium persulfate (ammonium peroxodisulfate), and the like are preferably used as water-soluble oxidizing agents. As the alkaline compound, those that are water-soluble and dissociate into monovalent cations and monovalent or divalent anions in the aqueous solution to show alkalinity are preferably used.For example, alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, lithium hydroxide, alkali metal carbonates such as lithium carbonate, sodium carbonate, potassium carbonate, alkali hydrogen carbonates such as sodium hydrogen carbonate, potassium hydrogen carbonate, alkali metal acetates such as sodium acetate, potassium acetate, ammonium acetate, alkali metal oxalates such as sodium oxalate, potassium oxalate, alkali metal succinates such as monosodium succinate, alkali metal salts of amino acids such as glycine, alanine, glutamic acid, and ammonia are preferred.Among them, sodium hydrogen carbonate and sodium hydroxide are preferred.
[0022] The pH of the aqueous composition for sterilization is not particularly limited as long as it is within the range of 1-10.
[0023] The concentration of the persulfate compound (oxidizing agent) in the aqueous composition for sterilization is not particularly limited, but is preferably, for example, 0.01% by weight or more and not more than the saturated concentration, and more preferably 0.01 to 8% by weight for potassium persulfate (KPS), 1 to 30% by weight for sodium persulfate, and 3 to 50% by weight for ammonium persulfate. The concentration of the alkaline compound in the aqueous composition for sterilization is not particularly limited, but is preferably, for example, from 0% by weight to 8% by weight. Furthermore, the temperature of the aqueous composition for sterilization is preferably in the range of 60° C. to 100° C. under normal pressure.
[0024] The sterilization method of the present invention comprises the step of sterilizing an object containing infectious microorganisms using the above-mentioned aqueous sterilization composition.
[0025] The infectious microorganism is preferably in a state of being dispersed in water, dispersed in a water-absorbent polymer gel, or attached or adsorbed to a solid surface.
[0026] The material of the treatment object to be applied to the sterilization method of the present invention must be a solid material that is not corroded by the aqueous sterilization composition, and examples of such materials include stainless steels such as SUS304, SUS316, etc., Pyrex glass, and polymeric materials such as polyethylene, polypropylene, cycloolefin polymer, polyacetal, nylon, polyphenylene ether, polyethylene terephthalate, polybutylene terephthalate, poly-L-lactic acid, polycarbonate, polyvinylidene fluoride, polytetrafluoroethylene, polyphenylsulfone, polyphenylene sulfide, polyether ether ketone, polyimide, homopolymers typified by common methyl vinyl silicone rubber, copolymers, blends, nonwoven fabrics, and composite materials such as fiber reinforced resins typified by CFRP.
[0027] Furthermore, the objects to be treated are not particularly limited, and examples thereof include sanitary products such as used paper diapers, medical protective clothing, medical equipment, fibers, films, food, various molded objects, products, and containers. Used paper diapers discarded from nursing homes for the elderly and the like are disposed of as general waste. However, used paper diapers discarded from medical institutions must be separated into general waste and infectious waste and treated separately. For this reason, separating used paper diapers is cumbersome for medical institutions, and the burden of processing costs is also large. The present invention allows used paper diapers to be sterilized collectively at low cost, safely, and simply in accordance with the processing standards for infectious waste, which is of great benefit to medical facilities.
[0028] In addition, in the present sterilization method, the sterilization of the object to be sterilized in the aqueous composition for sterilization can be carried out in a stationary state, or can be carried out appropriately with stirring or ultrasonic irradiation.
[0029] In this sterilization method, the time for treating the object to be treated in the aqueous composition for sterilization of the present invention (the time for decomposing (sterilizing) infectious microorganisms (decomposition time)) can be appropriately selected depending on the concentration of the oxidizing agent, the composition of the aqueous composition, and the temperature, and is not particularly limited, but is usually preferably 15 minutes to 3 hours, more preferably 30 minutes to 2 hours, and even more preferably 40 minutes to 1 hour.
[0030] In addition, in this sterilization method, the heating temperature of the aqueous composition for sterilization is preferably in the range of 60°C or higher and 100°C or lower in the case of sterilization of general bacteria, and preferably in the range of 70°C or higher and 100°C or lower in the case of sterilization of bacterial spores.
[0031] Furthermore, when the molar ratio of the alkaline compound to potassium persulfate (KPS) is less than about 2, the pH tends to decrease during the sterilization reaction. In this case, it is preferable to add an alkaline compound to the aqueous solution to neutralize it.
[0032] In addition, when used paper diapers are used as the object to be treated, since used paper diapers contain waste, i.e., feces and urine components, the aqueous composition for sterilization exhibits a foul odor and brown color derived from feces and urine during the sterilization reaction. However, by continuing the treatment for, for example, about 1 to 2 hours, the initial foul odor disappears and changes to a weak odor, so the treatment time can be appropriately changed depending on the object to be treated.
[0033] Although the sterilization method of the present invention can be carried out without providing a dedicated facility, a sterilization treatment device for treating used paper diapers will be described below as an example. The sterilization treatment device for used paper diapers is characterized by comprising an immersion section for storing an aqueous sterilization composition and immersing used paper diapers containing a paper diaper base material, a water-absorbent polymer, and waste in the aqueous solution, and a decomposition / sterilization reaction section for heating the used paper diapers and the aqueous sterilization composition to cause a decomposition reaction of the water-absorbent polymer and sterilize infectious microorganisms. The immersion section and the decomposition / sterilization reaction section are made of materials that will not be chemically deteriorated by the aqueous composition for sterilization. Examples of materials or coating materials for the device include stainless steel, Pyrex glass, fluororesins such as polytetrafluoroethylene (PTFE), polypropylene, etc., among which stainless steel is more preferable, and SUS304 stainless steel is most preferable. In this treatment device, the immersion section and the decomposition / sterilization reaction section may be independent of each other, or the immersion section may be heatable and used as the decomposition / sterilization reaction section so that the immersion process and the decomposition / sterilization reaction process can be performed continuously.
[0034] The aqueous composition for sterilization and the sterilization method using the same of the present invention are not limited to the above embodiments. EXAMPLES
[0035] The aqueous composition for sterilization of the present invention and the sterilization method using the same will be described below with reference to examples. However, the aqueous composition for sterilization and the sterilization method of the present invention are in no way limited to the following examples.
[0036] (Sterilization test method) As biological indicators of infectious microorganisms, sterilization tests were conducted for Geobacillus stearothermophilus (ATCC7953) and Bacillus atrophaeus (ATCC 9372), which are recognized in the "Manual for Infectious Waste Disposal Based on the Waste Disposal Law" as biological indicators that show equal or greater resistance to bacterial spores, as follows. The media used were (1) Tryptic Soy Agar (Difico, hereafter referred to as "TSA") and (2) SCDLP bouillon medium, and sodium chloride (manufactured by Wako Pure Chemical Industries, hereafter referred to as "0.85% solution in physiological saline") was used as the medium reagent. The test bacteria was Geobacillus stearothermophilus ATCC7953 (CROSSTEX spore liquid, Lot. AR579, approximately 10 9 CFU / mL, steam sterilization indicator spore bacteria) or Bacillus atrophaeus ATCC 9372 (NAMSA spore solution, Lot. N35105, approx. 10 9 CFU / mL, or CROSSTEX spore liquid, Lot. BT324, approximately 10 9 These stock solutions were subjected to testing using the spore suspension (CFU / mL, indicator bacteria for dry heat sterilization). To prepare the test solution, a predetermined amount of sterile distilled water was dispensed into a glass container, and the aqueous composition for sterilization was dissolved therein. In the bactericidal efficacy test, after preparing the test solution, the test solution was heated and kept at the test temperature within ±2°C, and 0.1 mL of the test bacteria solution was added, mixed, and allowed to act for a predetermined time. After the predetermined time had elapsed, 1 mL of the mixed solution was added to 9 mL of the inactivator SCDLP, whose effectiveness had been confirmed, to stop the bactericidal action against the test bacteria, and this was used as a sample solution for measuring the number of bacteria. As a control, physiological saline was used instead of the test solution and allowed to act in the same manner. The bacterial count was measured by preparing a 10-fold serial dilution series with physiological saline using the sample solution for bacterial count measurement as the stock solution, transferring 1 mL of each of the sample stock solution and dilution solution to a petri dish, mixing with approximately 20 mL of TSA, solidifying, and culturing Bacillus atrophaeus at 36±2°C and Geobacillus stearothermophilus at 52±2°C for 48 hours. The number of grown colonies after culturing was counted to determine the number of test bacteria per mL of sample solution (lower limit of quantification: 10 CFU). The log reduction value (LRV) and the reduction rate were calculated from the inoculated number of test bacteria and the number of bacteria in the test solution. The LRV was expressed to one decimal place (the second decimal place was rounded down). Here, an LRV value of 6 or more means that the aqueous composition for sterilization has reduced the number of bacteria in the sample solution to one millionth or less, i.e., that the aqueous composition for sterilization has excellent sterilization performance.
[0037] (Sterilization test of aqueous solution of bacterial spores) Example 1 In a Pyrex glass container (beaker), an aqueous composition for sterilization was prepared with 0.2 mol / L potassium persulfate (KPS) and 0.1 mol / L sodium bicarbonate, i.e., a molar ratio of 1 / 0.5. 9 mL of the aqueous composition for sterilization heated to 95±2°C was mixed with 0.1 mL of a Bacillus atrophaeus (ATCC 9372) solution to prepare a test solution (pH approximately 8). The number of inoculated bacteria was 2.2x10 7 The CFU / 1 mL of test solution was left to stand at the above temperature for 60 minutes to allow the decomposition agent to act on it. After that, 1 mL of the test solution was added and mixed with 9 mL of SCDLP medium in which the effectiveness of the inactivator was confirmed, the effect of the test solution was stopped, and the number of bacteria was measured. The number of bacteria after the sterilization test was 10 or less, and the LRV (log reduction value of bacteria) = log (number of inoculum bacteria / number of bacteria in solution after test) was greater than 6.4. This value indicates that the bacterial spores were reduced to approximately 1 / 2.5 million. This value is the sterility assurance level when the number of inoculum bacteria for sterilization is 10 -6This means that the concentration of sterilized bacteria was reduced to less than one millionth of that of normal bacteria. Therefore, it was revealed that the aqueous composition for sterilization has high sterilization performance against Bacillus atrophaeus (ATCC 9372), which is one of the biological indicators of strong sterilization resistance such as bacterial spores, at 95°C, which is lower than 100°C. In addition, the same sterilization tests were conducted in SUS304 stainless steel containers and polypropylene containers, and similar sterilization performance was obtained.
[0038] Example 2 A sterilization test was carried out under the same conditions as in Example 1, except that 0.2 mol / L potassium persulfate and 0.2 mol / L sodium bicarbonate (molar ratio 1 / 1) were used as the aqueous composition for sterilization. As a result, an LRV of >6.4 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0039] Example 3 A sterilization test was carried out under the same conditions as in Example 1, except that the temperature of the aqueous composition for sterilization was 90° C. As a result, an LRV of >6.4 was obtained after the sterilization test, and it was revealed that the aqueous solution of the treating agent has high sterilization performance even at 90° C., and that it is possible to sterilize bacterial spores at a lower temperature than in Example 1.
[0040] Example 4 A sterilization test was carried out under the same conditions as in Example 2, except that the temperature of the aqueous composition for sterilization was 90° C. As a result, an LRV of >6.4 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0041] Example 5 A sterilization test was carried out under the same conditions as in Example 1, except that the temperature of the aqueous composition for sterilization was 85° C. As a result, an LRV of >6.4 was obtained after the sterilization test, and it was revealed that the aqueous composition for sterilization has high sterilization performance at 85° C., which is 10° C. lower than that in Example 1.
[0042] Example 6 A sterilization test was carried out under the same conditions as in Example 1, except that the bacterial species was Geobacillus stearothermophilus (ATCC7953). As a result, the LRV after the sterilization test was > 6.2. This value is the sterility assurance level when the inoculum number for sterilization is 10 -6 This means that the concentration of sterilizing agent was reduced to less than one millionth of that of sterilizing agent. Therefore, it was revealed that the aqueous composition for sterilization of the present invention has high sterilization performance against Geobacillus stearothermophilus. Moreover, the aqueous composition for sterilization also showed neutrality under these conditions.
[0043] Example 7 A sterilization test was carried out under the same conditions as in Example 2, except that the bacterial species was Geobacillus stearothermophilus (ATCC7953). As a result, an LRV of >6.2 was obtained after the sterilization test, and it was revealed that the aqueous composition for sterilization had high sterilization performance, similar to that of Example 2.
[0044] Example 8 A sterilization test was carried out under the same conditions as in Example 3, except that the bacterial species was Geobacillus stearothermophilus (ATCC7953). As a result, an LRV of >6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0045] Example 9 A sterilization test was carried out under the same conditions as in Example 5, except that the bacterial species was Geobacillus stearothermophilus (ATCC7953). As a result, the LRV after the sterilization test was >6.2. This shows that the aqueous composition for sterilization has high sterilization performance at 85°C.
[0046] Example 10 A sterilization test was carried out under the same conditions as in Example 8, except that 0.1 mol / L potassium persulfate and 0.05 mol / L sodium hydrogen carbonate (molar ratio 2 / 1) were used as the aqueous composition for sterilization. As a result, even when the decomposition agent concentration was halved, an LRV > 6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0047] Example 11 A sterilization test was carried out under the same conditions as in Example 8, except that the reaction time was set to 20 minutes. As a result, even when the reaction time was shortened to 1 / 3, an LRV of > 6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0048] Example 12 A sterilization test was carried out under the same conditions as in Example 9 (the same conditions as in Example 11 except that the reaction temperature was 85° C.), except that the reaction time was 20 minutes. As a result, under milder conditions than in Examples 1 to 10, an LRV of 6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has sufficiently excellent sterilization performance.
[0049] (Example 13) A sterilization test was carried out against Bacillus atrophaeus (ATCC9372) under the same conditions as in Example 2 (temperature 95°C, reaction time 60 minutes), except that an aqueous solution consisting of only 0.2 mol / L potassium persulfate was used as the aqueous composition for sterilization. As a result, an LRV of >6.4 was obtained after the sterilization test, and it was revealed that the aqueous composition for sterilization has high sterilization performance. In this example, the aqueous solution was strongly acidic (pH about 1) from the start of the decomposition test, and care must be taken when handling it.
[0050] Example 14 A sterilization test was carried out under the same conditions as in Example 13, except that the decomposition temperature was set to 90° C. The results were the same as in Example 13, and an LRV of >6.4 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0051] Example 15 A sterilization test was carried out under the same conditions as in Example 13, except that the decomposition temperature was set to 85° C. The results were the same as in Example 13, and an LRV of >6.4 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0052] Example 16 A sterilization test was carried out under the same conditions as in Example 13, except that the bacterial species was Geobacillus stearothermophilus (ATCC7953). As a result, an LRV of >6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0053] (Example 17) A sterilization test was carried out under the same conditions as in Example 16, except that the decomposition temperature was set to 90° C. As a result, an LRV of >6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0054] (Example 18) A sterilization test was carried out under the same conditions as in Example 16, except that the decomposition temperature was set to 85° C. As a result, an LRV of >6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0055] (Example 19) A sterilization test was carried out under the same conditions as in Example 17 (temperature 90°C, reaction time 60 minutes) except that the aqueous composition for sterilization had a potassium persulfate concentration of 0.1 mol / L. As a result, an LRV of >6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0056] (Example 20) A sterilization test was carried out under the same conditions as in Example 19 (temperature 90°C, reaction time 60 minutes) except that the potassium persulfate concentration of the aqueous composition for sterilization was 0.05 mol / L. As a result, the LRV after the sterilization test was > 6.2, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0057] Example 21 A sterilization test was carried out under the same conditions as in Example 17, except that the reaction time was set to 20 minutes. As a result, even when the reaction time was shortened to 1 / 3, an LRV of > 6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0058] Example 22 A sterilization test was carried out under the same conditions as in Example 21 (reaction time: 60 minutes), except that the reaction temperature was 85° C. As a result, an LRV of 6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has excellent sterilization performance.
[0059] (Example 23) A sterilization test was carried out under the same conditions as in Example 21 (temperature 90°C, reaction time 20 minutes) except that the potassium persulfate concentration of the aqueous composition for sterilization was 0.1 mol / L. As a result, an LRV of >6.2 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0060] Example 24 A sterilization test was carried out under the same conditions as in Example 23 (temperature 90°C, reaction time 20 minutes) except that the aqueous composition for sterilization had a potassium persulfate concentration of 0.05 mol / L. As a result, an LRV of 6.1 was obtained after the sterilization test, demonstrating that the aqueous composition for sterilization has high sterilization performance.
[0061] (Example 25) A sterilization test was carried out on Bacillus atrophaeus at 70°C for 60 minutes in an aqueous sterilization composition consisting of only potassium persulfate at a concentration of 0.1 mol / L. Although the results did not reach the sterility assurance level, it was found that the LRV was 5, i.e., the number of bacterial spores was killed to 1 / 100,000. This value meets the required performance for sterilization according to the aforementioned international standard. It is also estimated that if the reaction is continued for a longer period of time, the LRV may reach 6.
[0062] (Example 26) A sterilization test was carried out on Bacillus atrophaeus in an aqueous sterilization composition consisting of 0.2 mol / L potassium persulfate and 0.2 mol / L sodium bicarbonate at 85°C for 60 minutes. As a result, although the sterility assurance level was not reached, an LRV of 5 was obtained, indicating that a high sterilization effect was obtained. This value meets the required performance for sterilization according to the above-mentioned international standard. It is estimated that the LRV may reach 6 if the reaction is continued for a longer period of time. Note that an aqueous sterilization composition having the same composition as this one achieved an LRV of > 6.4 at 90°C for 60 minutes, as shown in Example 4.
[0063] Example 27 A sterilization test was carried out on Bacillus atrophaeus in an aqueous sterilization composition consisting of 0.1 mol / L potassium persulfate and 0.05 mol / L sodium bicarbonate at 90°C for 20 minutes. As a result, although the sterility assurance level was not reached, an LRV of 5.9 was obtained, indicating that a certain degree of sterilization effect was obtained. This value meets the required performance for sterilization according to the aforementioned international standard. In this case, it is estimated that the LRV may reach 6 with a reaction time of 30 minutes.
[0064] The results of Examples 1 to 27 are shown in Table 1. [Table 1]
[0065] (Materials resistant to corrosion by aqueous sterilization compositions) The aqueous composition for sterilization of the present invention has excellent performance in destroying bacterial spores as described above, and contains an oxidizing agent as a decomposition agent. Therefore, it is essential that the material (stainless steel, Pyrex glass, various polymeric materials, etc.) of the object to be treated (sterilization treatment device, etc.) to which the bacterial spores adhere or adsorb in carrying out the sterilization treatment has resistance to deterioration (corrosion resistance) against the aqueous composition for sterilization. Therefore, a deterioration resistance test will be shown below and described in more detail.
[0066] (Example 28) Four samples (approximately 10 x 10 x 0.5 mm, weights: 3.990g, 3.976g, 3.967g, 3.977g) cut from commercially available SUS304 stainless steel plates were individually placed in a 0.1 mol / L potassium persulfate (KPS) aqueous solution (90°C) in a Pyrex glass vial, and a corrosion test was performed on the stainless steel plate samples for 60 minutes. After the test, the samples were ultrasonically cleaned several times in distilled water, then immersed in ethanol, stirred, and thoroughly air-dried on filter paper. The weights of the four samples obtained after treatment with the decomposition agent were measured, and no weight change was observed in any of the samples. Furthermore, the SEM images (magnification: 1000x) taken using an Elionix scanning electron microscope ERA8900 showed no change before and after treatment. These results demonstrate that the aqueous composition for sterilization of the present invention does not corrode the stainless steel plate at temperatures below 100° C., making it suitable for use as a treatment container for sterilizing bacterial spores. Therefore, it can be said that other stainless steels with corrosion resistance superior to that of SUS304 stainless steel plate are also suitable for sterilization with the aqueous composition for sterilization.
[0067] (Example 29) A corrosion test (deterioration test) was carried out under the same conditions as in Example 28, except that a test piece of 0.259 g cut out from a TPX beaker (material: PMP: polymethylpentene, a product capable of autoclave sterilization at 121°C for 20 minutes) listed in the catalog of AS ONE Corporation was used. As a result, the test piece did not change in weight or shape due to the treatment, and it was revealed that the polymethylpentene sample is suitable as a plastic material with excellent corrosion resistance for a container for sterilization of the aqueous composition for sterilization of the present invention. In addition, the physical properties of general polymethylpentene are that it has the highest melting point of about 235°C among polyolefins, is the lightest at 0.83 in density, has the second lowest surface tension after fluororesin, and has creep properties superior to polyethylene and polypropylene, and therefore has recently been used in beakers, petri dishes, graduated cylinders, syringes, etc., instead of glass. From this fact, it can be said that polymethylpentene is also a suitable material for sterilization of bacterial spores in the aqueous composition for sterilization of the present invention.
[0068] (Example 30) A corrosion test (deterioration test) was carried out under the same conditions as in Example 28, except that 0.058 g of test piece film cut out from a gamma-ray sterilized disposable beaker (polypropylene, translucent) listed in the general catalog of Sansho Co., Ltd. was used. As a result, the test piece did not change in weight or shape due to the treatment, and it was revealed that the gamma-ray sterilized polypropylene film sample is a plastic material with excellent corrosion resistance and is suitable for containers for sterilization treatment using the aqueous composition for sterilization of the present invention. In addition, when a deterioration test was carried out in the aqueous composition for sterilization of the present invention for a test piece of crystalline polypropylene (iPP: isotactic polypropylene) with a melting temperature of about 175°C, the surface shape did not change at all. From the above results, it can be said that polypropylene is a suitable material for containers for sterilization treatment using the aqueous composition for sterilization of the present invention.
[0069] (Example 31) A corrosion test (deterioration test) was carried out under the same conditions as in Example 28, except that 0.022 g of test piece film was cut out from Lumirror film (PET: polyethylene terephthalate film, thickness 100 μm, T60 transparent product) listed in the catalog of AS ONE Corporation was used. As a result, the test piece film did not change in weight or shape due to the treatment, and it was revealed that the PET film is a suitable material that is not deteriorated by the aqueous composition for sterilization of the present invention.
[0070] Example 32 A corrosion test (deterioration test) was carried out under the same conditions as in Example 28, except that a test piece sheet of 0.406 g cut out from a Naflon sheet (PTFE: polytetrafluoroethylene sheet, thickness 1.0 mm) listed in the catalog of AS ONE Corporation was used. As a result, the test piece film did not change in weight or shape due to the treatment, and it was revealed that the PTFE sheet is a suitable material that is not deteriorated by the aqueous composition for sterilization of the present invention.
[0071] A list of Examples 28 to 32 is shown in Table 2. [Table 2]
[0072] From the above results, it has become clear that the aqueous composition for sterilization of the present invention is an excellent sterilant that can be used at normal pressure and below 100°C, without the risk of generating or leaving behind gases that cause health hazards such as ethylene oxide and glutaraldehyde, and furthermore, can significantly reduce the deterioration of materials to be sterilized under high temperature and pressure. In other words, it has become clear that the sterilization method of the present invention not only makes it possible to sterilize many medical devices and instruments that are contaminated with not only general bacteria but also all infectious microorganisms such as bacterial spores, and that there are no particular limitations on the materials of containers for the sterilization. [Industrial Applicability]
[0073] As described above, it has been demonstrated that the aqueous composition for sterilization of the present invention does not generate gases that are harmful to human health or the environment, and has excellent sterilization performance at atmospheric pressure and below 100°C. It has become clear that the sterilization method of the present invention is extremely superior to conventional sterilization methods in terms of safety, convenience, and a wide range of options for sterilized containers, sterilized control products, etc., and has the potential to be applied to a wide range of treatment objects.
Claims
1. An aqueous sterilization composition for sterilizing infectious microorganisms, comprising a persulfate compound.
2. 2. The sterilizing aqueous composition of claim 1, wherein the persulfate compound is water-soluble.
3. 2. The sterilizing aqueous composition according to claim 1, wherein the persulfate compound is peroxodisulfate.
4. 2. The aqueous composition for sterilization according to claim 1, wherein the concentration of the persulfate compound in the aqueous composition for sterilization is 0.01% by weight or more and a saturation concentration or less.
5. 2. The aqueous composition for sterilization according to claim 1, further comprising an alkaline compound.
6. 2. The aqueous composition for sterilization according to claim 1, wherein the pH of the aqueous composition for sterilization is in the range of 1 to 10.
7. A method for sterilizing infectious microorganisms, comprising a step of sterilizing an object containing the infectious microorganisms with the aqueous composition for sterilization according to any one of claims 1 to 6.
8. The infectious microorganism Dispersed in water, Dispersed in a water-absorbent polymer gel, or Adhered or adsorbed to a solid surface The sterilization method according to claim 7,
9. The sterilization method according to claim 7, wherein the object to be sterilized is a medical tool or medical device.
10. The sterilization method according to claim 9, wherein the object to be sterilized is medical protective clothing.
11. 8. The sterilization method according to claim 7, wherein the object to be sterilized is a paper diaper.
12. 8. The sterilization method according to claim 7, wherein the object to be sterilized is a food product.
Citation Information
Patent Citations
Device and method for sterilizing medical protective clothing
DE102020109538A1
Method for producing disinfectant solution containing chlorine dioxide for water treatment
JP1999503995A
detergents and disinfectants
JP2004510878A
water treatment
JP2008507399A
Generation of peroxyformic acid through polyhydric alcohol formate
JP2021008471A
Cited By
Member, and semiconductor manufacturing–related device
WO2026205262A1
